Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Proponents often emphasize the potential for meaningful therapeutic gains, especially in conditions where conventional therapies have proven limited. However, crucially important to evaluate the considerable financial expenditure associated with CPI